People: Agilent Technologies Inc (A.N)

A.N on New York Stock Exchange

23 Aug 2019
Change (% chg)

$-2.19 (-3.05%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Bishop, Hans 

Mr. Hans Edgar Bishop serves as Independent Director of the Company. Mr. Bishop served as president, chief executive officer and a member of the Board of Directors of Juno Therapeutics, Inc. from September 2013 to March 2018 when Juno was acquired by Celgene Corporation. From February 2012 until October 2012, Mr. Bishop was the chief operating officer of Photothera Inc., a late-stage medical device company owned by Warburg Pincus, and he continued working with Warburg Pincus as an Executive in Residence until October 2013. Prior to joining Photothera Inc., Mr. Bishop served as executive vice president and chief operating officer at Dendreon Corporation, a publicly-traded biopharmaceutical company, from January 2010 to September 2011. Mr. Bishop has also served as the president of the specialty medicine business at Bayer Healthcare Pharmaceuticals Inc. from December 2006 to January 2010, where he was responsible for a diverse portfolio of neurology, oncology and hematology products.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 194,044
Long-Term Incentive Plans, USD --
All Other, USD 66,667
Fiscal Year Total, USD 260,711

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --